Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Celularity Inc
(NQ:
CELU
)
1.630
-0.060 (-3.56%)
Streaming Delayed Price
Updated: 2:59 PM EDT, Oct 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Celularity Inc
Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting
June 03, 2024
Company presents results from in vivo studies of PT-CD16VS, a genetically modified allogeneic cell therapy derived from human placental circulating T (P-T) cells, in combination with various monoclonal...
From
Celularity Inc.
Via
GlobeNewswire
Celularity Inc. to Host Investor and Analyst Research & Development Day
April 22, 2024
Event Will Be Hosted On-site and Aired Virtually Highlighting Research, Clinical and Commercial Progress
From
Celularity Inc.
Via
GlobeNewswire
Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products
April 15, 2024
From
Celularity Inc.
Via
GlobeNewswire
Celularity and CH Trading Group Announce Product Distribution Agreement with Tamer Group to be the Exclusive Distributor for the Kingdom of Saudi Arabia
January 11, 2023
From
Celularity Inc.
Via
Business Wire
Celularity and CH Trading Group Announce Territory Distribution Agreement for the Middle East
January 11, 2023
From
Celularity Inc.
Via
Business Wire
CIRCLE H INTERNATIONAL (Ⓗ®™) SHARIA ADVISORY COUNCIL ISSUES UNPRECEDENTED FATWA FOR CONDITIONAL PERMITTED USE OF STEM CELLS, EXOSOMES, AND BIOMATERIALS IN RESEARCH, CLINICAL TRIALS AND TREATMENT
December 20, 2022
New York, New York, United States - 12-20-2022 (PR Distribution™) -
Via
PR Distribution
Topics
Religion
Exposures
Religion
Celularity Announces Halal Certification of its Advanced Cellular Therapeutics, Biomaterial Products and Business Model
December 05, 2022
From
Celularity Inc.
Via
Business Wire
Celularity CEO Robert J. Hariri, M.D., Ph.D., Addresses FII Conference on “The Science and Technology for Extending Healthy Human Lifespan”
November 30, 2022
From
Celularity, Inc.
Via
Business Wire
How Aging-Related Conditions Are Increasing The Treatment Burden For Older Patients
August 13, 2021
Via
FinancialNewsMedia
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.